Biopharma Business

Tag "AstraZeneca"

FDA approves Bydureon BCise for patients with type-2 diabetes

    FDA approves Bydureon BCise for patients with type-2 diabetes

The FDA has approved Bydureon BCise for adults with type-2 diabetes whose blood sugar remains uncontrolled on one or more oral medicines. AstraZeneca has announced that the US Food and Drug Administration

Read Full Article

FDA accepts regulatory submission for Lynparza in metastatic breast cancer

    FDA accepts regulatory submission for Lynparza in metastatic breast cancer

Lynparza has the potential to offer a new treatment option for patients with metastatic breast cancer. AstraZeneca and Merck & Co., have announced that the US Food and Drug Administration

Read Full Article

Brilique (ticagrelor) new formulation gains European approval

    Brilique (ticagrelor) new formulation gains European approval

The European Commission (EC) has granted marketing authorisation for AstraZeneca’s Brilique (ticagrelor) orodispersible tablets (ODT) as a new method of treatment administration. This decision means that ticagrelor will become the

Read Full Article

Global European Rights to AstraZeneca’s Heart Failure Treatment Acquired by Recordati for $300M

    Global European Rights to AstraZeneca’s Heart Failure Treatment Acquired by Recordati for $300M

Recordati announced that it has entered into an agreement with AstraZeneca for the acquisition of the rights to Seloken®/Seloken® ZOK (metoprolol succinate) and associated Logimax® fixed dose combination (metoprolol succinate

Read Full Article

MedImmune and Sanofi Pasteur form alliance to develop and commercialise potential next-generation respiratory syncytial virus antibody MEDI8897

MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, have announced an agreement to develop and commercialise MEDI8897 jointly. MEDI8897 is

Read Full Article

Collaboration tackles respiratory irritancy hazard

SenzaGen and AstraZeneca will develop a new genomic signature to distinguish allergens from irritants in the respiratory tract Swedish in vitro testing company, SenzaGen, has signed a collaboration agreement with

Read Full Article

Sanofi and AstraZeneca to Collaborate on Antibody for Prevention of Respiratory Illnesses

Sanofi and its vaccines global business unit Sanofi Pasteur announced today an agreement with MedImmune, the global biologics research and development arm of AstraZeneca, to develop and commercialize a monoclonal antibody–called MEDI8897–for the

Read Full Article

Upcoming Events

  • No upcoming events
AEC v1.0.4

The Magazine

New Subscriber

Subscribe Here



Advertisements